Sponsored

Baker McKenzie lawyers consider how foreign companies should approach the US’ famous Foreign Corrupt Practices Act when the goalposts keep moving

The US agency has used recent enforcement actions to highlight the importance of maintaining sanctions compliance programmes

Prager Dreifuss counsel Michael Mosimann, who advises startups on public offerings, reviews how Switzerland’s legislative framework supports blockchain

Companies are facing legal and operational challenges when it comes to the global move away from interbank offered rates

For companies in financial distress, strengthening the equity base is typically one of the key pillars of a successful turnaround, as lowering the leverage ratio and improving the rating can help to reduce debt financing costs substantially. On top of this, certain (potential) business partners may refuse to engage in or discontinue business dealings with the distressed company if they have doubts about its creditworthiness which can further deteriorate the company's situation. This article sets out a non-exhaustive list of possible routes for a Swiss company (issuer) listed on the SIX Swiss Exchange (SIX) to conduct an equity raise in such a situation which requires, in particular, that the following two requirements can be achieved:

Latham & Watkins lawyers, counsel to World Bank on the milestone transaction, discuss the creation of this new asset class and how the model can be adapted by other issuers

Public procurement rules and procedures in Macau at the moment are spread among the different statutes that regulate the different types of contracts that can be entered into with/by Macau public entities. However the government is preparing a Bill with the goal of simplifying and updating, as well as enhancing the public procurement legal regime.

Regulators are keeping a close eye on HFT following the October trading system glitch on the TSE. Here Morgan Lewis & Bockius lawyers review the new landscape

The EU General Court’s judgment last summer confirmed that PE firms are not immune to antitrust risks